Read articles from Global
September 28, 2026 by substack.com
Why Nicotine Pouches Win
Nicotine pouches are gaining ground because they solve practical problems that policy often overlooks. They are smoke-free, discreet, easy to use and do not require combustion, making them a workable alternative for adults who want nicotine without cigarettes. Their success should not be treated as a mystery or a threat by default. It should be understood as a signal that consumers respond to products that fit real life while reducing exposure to the harms of smoking.
September 23, 2026 by substack.com
Flaws of Electronic Medical Record (EMR) Studies
Electronic medical records can look objective while still giving researchers a distorted view of behaviour. Smoking status, vaping history, dual use and switching are often recorded incompletely or reduced to crude categories that miss the timing and direction of change. For nicotine research, those gaps matter because the difference between “ever used” and “switched away from cigarettes” can alter the entire interpretation of risk. Better data means better science — and better science means better policy.
September 21, 2026 by snusforumet.se
Alex Wodak: ‘The safer nicotine option should be the easier option’
The safer nicotine option should be the easier option. That principle is simple, but many policies still do the opposite by keeping cigarettes familiar, affordable or accessible while making lower-risk alternatives harder to find or understand. Adult smokers need a path away from combustion that is practical in the real world, not only acceptable in theory. Harm reduction works best when regulation makes the less harmful choice the obvious one.
September 21, 2026 by substack.com
Mike Bloomberg's gift to Big Tobacco
Tobacco control can end up protecting cigarettes even when that is the opposite of its intention. Policies that restrict or stigmatise lower-risk nicotine alternatives may leave combustible tobacco with less competition and adult smokers with fewer viable exits. That is the uncomfortable contradiction at the heart of many anti-vaping campaigns. Public health should scrutinise industry influence, but it should also ask whether its own strategies are keeping the most harmful product in the strongest position.
September 18, 2026 by gfn.tv
When Happens When Moral Panic Drives Nicotine Policy? | GFN Interviews #96
Moral panic makes nicotine policy louder but not smarter. It pushes debate towards fear, urgency and symbolic restriction, while the harder questions about smoking, relative risk and consumer behaviour get pushed aside. The result can be regulation that feels protective but leaves adult smokers with fewer credible routes away from cigarettes. Public health needs evidence, proportion and calm enough to tell the difference between a real risk and a politically useful alarm.
September 16, 2026 by github.io
Taiwan: You Are Welcomed to Smoke, You Are Punished for Vaping
Taiwan’s nicotine policy draws a stark line in the wrong place: cigarettes remain legal while vapes are banned. That leaves adult smokers with fewer lower-risk options and keeps combustible tobacco as the most familiar legal choice. A health-focused framework should distinguish between products that burn tobacco and products that can reduce exposure by removing combustion. Public health policy should make the safer route easier to take, not harder to reach.
September 15, 2026 by liberalism.org
When Tobacco Is Illicit
Illicit tobacco is what happens after policy stops accounting for demand. High taxes, restricted safer alternatives and confidence in top-down control can turn nicotine into a market run less by retailers and more by criminal networks. That weakens age checks, product standards and public oversight while keeping cigarettes cheap for those willing to buy outside the law. The lesson is uncomfortable but clear: reducing harm requires legal pathways that work better than the illicit ones.
September 14, 2026 by gfn.tv
Why Is Harm Reduction Different for Smokers?
Harm reduction feels different for smokers because tobacco control has often treated nicotine use as a moral problem rather than a risk continuum. People who smoke need realistic ways to reduce exposure to the harms of combustion, especially after repeated quit attempts. Safer nicotine products do not remove every risk, but they can change the scale of harm dramatically. Public health should meet smokers with practical options, not only expectations of abstinence.
September 11, 2026 by abc.net.au
Labor Moves to Make Illicit Tobacco Prosecutions Easier With New Laws
Labor is cracking down on the illicit tobacco trade with new offences targeting organised crime, distributors and retailers selling illegal cigarettes.
The changes would also make it easier to seize the profits and assets of criminals involved in the black market.
September 11, 2026 by eichor.com
Multi-Site Trial of Tirzepatide for Smoking Cessation
This multi-site clinical trial will generate data on the efficacy of tirzepatide for smoking cessation and associated outcomes (e.g., post-cessation weight gain) in treatment-seeking people who smoke (PWS) with overweight or obesity. A sample of (...)
- Page 1 of 167